Our blog provides updates on Absolute Antibody’s technologies, products and services. Browse the latest posts to learn about company developments and events.

Over 30% of ‘monoclonal’ antibodies are not actually monoclonal

Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology

An Antibody Sequencing Story

Saving CP9/19 At Absolute Antibody, we specialise in the sequencing, engineering, and recombinant expression of antibodies and Fc Fusion proteins. …

Absolute Antibody Growth and Investment Accelerates

An Antibody Sequencing Story

Absolute Antibody licenses a further 31 monoclonal antibodies from Ximbio

Absolute Antibody announce licensing of 45 monoclonal antibodies from the Medical Research Council for recombinant manufacture

Absolute Antibody In Nature